Business Wire

CA-ZYNGA

1.6.2020 13:02:07 CEST | Business Wire | Press release

Share
Zynga Enters Into Agreement to Acquire Istanbul-based Peak, Creator of Top Charting Mobile Franchises Toon Blast and Toy Blast

Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, today announced it has entered into a definitive agreement to acquire Peak, one of the most globally successful mobile gaming companies, for $1.8 billion. Peak brings a 100-person strong team and two Forever Franchises, Toon Blast and Toy Blast , that have consistently ranked in the top 10 and top 20 U.S. iPhone grossing games for over two years, respectively. These franchises add significant scale to Zynga’s live services and will be an additional driver of margin expansion over the coming years. Peak also enhances Zynga’s new game pipeline with additional projects in early development.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200601005142/en/

Founded in 2010 by Sidar Sahin, Peak has developed the beloved game franchises Toon Blast and Toy Blast . Known for their innovation, creativity and exquisite design, Toon Blast and Toy Blast popularized the ‘collapse’ mechanic within match-3 puzzle games, and have captured a highly engaged global audience base that ranks among the industry's best in player retention. Collectively, Toon Blast and Toy Blast have more than 12 million average mobile DAUs. Peak is expected to grow Zynga’s average mobile DAUs by more than 60% while strengthening Zynga’s international audience.

“We are honored to welcome Sidar and team to Zynga. Peak is one of the world’s best puzzle game makers and we could not be more excited to add such creative and passionate talent to our company,” said Frank Gibeau, Chief Executive Officer of Zynga. “With the addition of Toon Blast and Toy Blast , we are expanding our live services portfolio to eight forever franchises, meaningfully increasing our global audience base and adding to our exciting new game pipeline. As a combined team, we are well positioned to grow faster together.”

“This is a monumental partnership not only for Zynga and Peak, but for the whole mobile gaming industry,” said Sidar Sahin, founder and Chief Executive Officer of Peak. “Both companies share a common vision -- to bring people together through games. Peak’s culture is rooted in relentless learning and progress, so as we embark on this new chapter in our journey together with Zynga, we remain as committed as ever to our unique culture. We’re very excited for our combined future and what we will accomplish together.”

Zynga will acquire 100% of Peak for $1.8 billion, comprised of approximately $900 million in cash and approximately $900 million of Zynga common stock (issued at the volume-weighted average closing price per share over the thirty-day trading period ended May 29, 2020). The final upfront transaction consideration will also include customary closing adjustments, and the transaction is expected to close in the third quarter of 2020.

Editor’s note:
Key art and broadcast assets available for use at the following link: https://bit.ly/ZyngaKeyArtandVideo

Q2 and Full Year 2020 Guidance Update

Based on strength across its live services portfolio, Zynga is updating its Q2 and Full Year 2020 financial guidance.

This update does not include any contributions from Peak, as the transaction is subject to customary closing conditions and is anticipated to close in the third quarter of 2020.

 

 

 

 

 

 

 

 

 

 

 

 

 

(In millions, except per share data, unaudited)

 

Prior Q2'20
Guidance as of
5/6/2020

 

 

Zynga Update

 

 

Updated Q2'20
Guidance as of
6/1/2020

 

Reconciliation of Revenue to Bookings

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

 

400

 

$

 

30

 

$

 

430

 

Change in deferred revenue

 

 

60

 

 

 

10

 

 

 

70

 

Bookings

$

 

460

 

$

 

40

 

$

 

500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Net Loss to Adjusted EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

 

(60

)

$

 

(100

)

$

 

(160

)

Contingent consideration fair value adjustment

 

 

25

 

 

 

100

 

 

 

125

 

Acquisition-related transaction expenses

 

 

1

 

 

 

3

 

 

 

4

 

Other reconciling items1

 

 

66

 

 

 

 

 

 

66

 

Adjusted EBITDA

$

 

32

 

$

 

3

 

$

 

35

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted net loss per share

$

 

(0.06

)

$

 

(0.11

)

$

 

(0.17

)

GAAP basic and diluted shares

 

 

960

 

 

 

 

 

 

960

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 See further detail in the Reconciliation of GAAP to Non-GAAP tables within the Non-GAAP Financial Measures section

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(In millions, except per share data, unaudited)

 

Prior FY2020
Guidance as of
5/6/2020

 

 

Zynga Update

 

 

Updated FY2020
Guidance as of
6/1/2020

 

Reconciliation of Revenue to Bookings

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

 

1,650

 

$

 

40

 

$

 

1,690

 

Change in deferred revenue

 

 

150

 

 

 

 

 

 

150

 

Bookings

$

 

1,800

 

$

 

40

 

$

 

1,840

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Net Loss to Adjusted EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

 

(245

)

$

 

(105

)

$

 

(350

)

Contingent consideration fair value adjustment

 

 

200

 

 

 

100

 

 

 

300

 

Provision for income taxes

 

 

40

 

 

 

10

 

 

 

50

 

Acquisition-related transaction expenses

 

 

3

 

 

 

8

 

 

 

11

 

Other reconciling items1

 

 

212

 

 

 

 

 

 

212

 

Adjusted EBITDA

$

 

210

 

$

 

13

 

$

 

223

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted net loss per share

$

 

(0.25

)

$

 

(0.11

)

$

 

(0.36

)

GAAP basic and diluted shares

 

 

965

 

 

 

 

 

 

965

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 See further detail in the Reconciliation of GAAP to Non-GAAP tables within the Non-GAAP Financial Measures section

 

Webcast and Conference Call Information

Zynga management will host a conference call at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) today to discuss the transaction and updates to the Company’s Q2 and Full Year 2020 guidance.

The conference call can be accessed at http://investor.zynga.com – a replay of which will be available through the website after the call – or via the below conference dial-in number:

  • Toll-Free Dial-In Number: (800) 537-0745
  • International Dial-In Number: (253) 237-1142
  • Conference ID: 1994758

About Zynga Inc.

Zynga is a global leader in interactive entertainment with a mission to connect the world through games. To date, more than one billion people have played Zynga’s franchises including CSR Racing TM , Empires & Puzzles TM , Merge Dragons! TM , Merge Magic! TM , Words With Friends TM and Zynga Poker TM . Zynga’s games are available in more than 150 countries and are playable across social platforms and mobile devices worldwide. Founded in 2007, the company is headquartered in San Francisco with locations in the U.S., Canada, U.K., Ireland, India, Turkey and Finland. For more information, visit www.zynga.com or follow Zynga on Twitter , Instagram , Facebook or the Zynga blog .

About Peak

Peak is a leading mobile gaming company powered by a team that values relentless progress. Peak believes the best products are created when talented people form autonomous teams that strive for impact. Peak currently has two top charting mobile franchises -- Toon Blast and Toy Blast -- that have consistently ranked within the top 10 and top 20 U.S. iPhone grossing games for the past two years, respectively, and collectively have more than 12 million average mobile DAUs. Peak, founded in 2010, is based in Istanbul, Turkey. For more information visit www.peak.com .

Forward-Looking Statements

This press release contains forward-looking statements, including those statements relating to our outlook for the second quarter and full year under the heading "Q2 and Full Year 2020 Guidance Update,” “Reconciliation of GAAP to Non-GAAP Updated Second Quarter 2020 Guidance,” and “Reconciliation of GAAP to Non-GAAP Updated Fiscal Year 2020 Guidance” and statements relating to, among other things: our ability to achieve the intended benefits of acquiring Peak Oyun Yazılım ve Pazarlama Anonim Şirketin (“Peak”), including expanding our global audience, growing our average mobile DAU and adding to our development pipeline and our overall growth; the purchase price for acquiring Peak; the form and allocation of deal consideration; the timing in which the transaction close is expected; and our ability to achieve financial projections, including revenue, bookings, income and margin goals. Forward-looking statements often include words such as “outlook,” “projected,” “planned,” “intends,” “will,” “anticipate,” “believe,” “target,” “expect,” and statements in the future tense are generally forward-looking. The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties, and assumptions. Undue reliance should not be placed on such forward-looking statements, which are based on information available to us on the date hereof. We assume no obligation to update such statements. More information about these risks, uncertainties, and assumptions are or will be described in greater detail in our public filings with the Securities and Exchange Commission (the “SEC”), copies of which may be obtained by visiting our Investor Relations website at http://investor.zynga.com or the SEC’s web site at www.sec.gov .

Key Operating Metrics

We manage our business by tracking several operating metrics, including Mobile DAUs. “Mobile DAUs,” which measure daily active users of our mobile games, is recorded and estimated by our internal analytics systems. We determine Mobile DAUs and other operating metrics by using internal company data based on tracking of user account activity. We also use information provided by third parties, including third party network logins provided by platform providers, to help us track whether a player logged in under two or more different user accounts is the same individual.

Mobile DAUs. We define Mobile DAUs as the number of individuals who played one of our mobile games during a particular day. Average Mobile DAUs for a particular period is the average of the Mobile DAUs for each day during that period. Under this metric, an individual who plays two different mobile games on the same day is counted as two DAUs. We use Mobile DAUs as a measure of audience engagement.

Non-GAAP Financial Measures

We have provided in this press release certain non-GAAP financial measures to supplement our consolidated financial statements prepared in accordance with U.S. GAAP (our “GAAP financial statements”). Management uses non-GAAP financial measures internally in analyzing our financial results to assess operational performance and liquidity. Our non-GAAP financial measures may be different from non-GAAP financial measures used by other companies.

The presentation of our non-GAAP financial measures is not intended to be considered in isolation or as a substitute for, or superior to, our GAAP financial statements. We believe that both management and investors benefit from referring to our non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. We believe our non-GAAP financial measures are useful to investors because they allow for greater transparency with respect to key financial measures we use in making operating decisions and because our investors and analysts use them to help assess the health of our business.

We have provided reconciliations of our non-GAAP financial measures used in this press release to the most directly comparable GAAP financial measures in the following tables. Because of the following limitations of our non-GAAP financial measures, you should consider the non-GAAP financial measures presented in this letter with our GAAP financial statements.

Key limitations of our non-GAAP financial measures include:

  • Bookings does not reflect that we defer and recognize online game revenue and revenue from certain advertising transactions over the estimated average playing period of payers for durable virtual items or as consumed for consumable virtual items;
  • Adjusted EBITDA does not include the impact of stock-based compensation expense, acquisition-related transaction expenses, contingent consideration fair value adjustments and legal settlements and related legal expenses;
  • Adjusted EBITDA does not reflect provisions for or benefits from income taxes and does not include other income (expense) net, which includes foreign exchange and asset disposition gains and losses, interest expense and interest income; and
  • Adjusted EBITDA excludes depreciation and amortization of tangible and intangible assets. Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future.

ZYNGA INC.

RECONCILIATION OF GAAP TO NON-GAAP UPDATED SECOND QUARTER 2020 GUIDANCE

(In millions, except per share data, unaudited)

 

 

 

Prior Q2'20
Guidance as of
5/6/2020

 

 

Zynga Update

 

 

Updated Q2'20
Guidance as of
6/1/2020

 

Reconciliation of Revenue to Bookings

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

 

400

 

$

 

30

 

$

 

430

 

Change in deferred revenue

 

 

60

 

 

 

10

 

 

 

70

 

Bookings

$

 

460

 

$

 

40

 

$

 

500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Net Loss to Adjusted EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

 

(60

)

$

 

(100

)

$

 

(160

)

Provision for income taxes

 

 

10

 

 

 

 

 

 

10

 

Interest income

 

 

(2

)

 

 

 

 

 

(2

)

Interest expense

 

 

8

 

 

 

 

 

 

8

 

Depreciation and amortization

 

 

20

 

 

 

 

 

 

20

 

Acquisition-related transaction expenses

 

 

1

 

 

 

3

 

 

 

4

 

Contingent consideration fair value adjustment

 

 

25

 

 

 

100

 

 

 

125

 

Stock-based compensation expense

 

 

30

 

 

 

 

 

 

30

 

Adjusted EBITDA

$

 

32

 

$

 

3

 

$

 

35

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted net loss per share

$

 

(0.06

)

$

 

(0.11

)

$

 

(0.17

)

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP basic and diluted shares

 

 

960

 

 

 

 

 

 

960

 

ZYNGA INC.

RECONCILIATION OF GAAP TO NON-GAAP UPDATED FISCAL YEAR 2020 GUIDANCE

(In millions, except per share data, unaudited)

 

 

 

Prior FY2020
Guidance as of
5/6/2020

 

 

Zynga Update

 

 

Updated FY2020
Guidance as of
6/1/2020

 

Reconciliation of Revenue to Bookings

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

$

 

1,650

 

$

 

40

 

$

 

1,690

 

Change in deferred revenue

 

 

150

 

 

 

 

 

 

150

 

Bookings

$

 

1,800

 

$

 

40

 

$

 

1,840

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Net Loss to Adjusted EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

 

(245

)

$

 

(105

)

$

 

(350

)

Provision for income taxes

 

 

40

 

 

 

10

 

 

 

50

 

Other expense (income), net

 

 

2

 

 

 

 

 

 

2

 

Interest income

 

 

(10

)

 

 

 

 

 

(10

)

Interest expense

 

 

30

 

 

 

 

 

 

30

 

Depreciation and amortization

 

 

80

 

 

 

 

 

 

80

 

Acquisition-related transaction expenses

 

 

3

 

 

 

8

 

 

 

11

 

Contingent consideration fair value adjustment

 

 

200

 

 

 

100

 

 

 

300

 

Stock-based compensation expense

 

 

110

 

 

 

 

 

 

110

 

Adjusted EBITDA

$

 

210

 

$

 

13

 

$

 

223

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted net loss per share

$

 

(0.25

)

$

 

(0.11

)

$

 

(0.36

)

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP basic and diluted shares

 

 

965

 

 

 

 

 

 

965

 

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye